Mei Liu

机构：Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-7073-6174

发表论文 252 篇 · 总被引 7428 次 · h-index 41

代表论文

• Targeting Lactylation: From Metabolic Reprogramming to Precision Therapeutics in Liver Diseases (2025 · Biomolecules · 被引 12)
• Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 8)
• A20-mediated KEAP1 ubiquitination orchestrates hepatocyte ferroptosis to ameliorate autoimmune hepatitis (2025 · Gut · 被引 7)
• Serum amyloid A1–induced intrahepatic regulatory T-cell dysfunction drives autoimmune hepatitis progression (2025 · Hepatology · 被引 6)
• Current Perspectives on the Inflammatory Bowel Disease Pathogenesis of Microbiota and the Gut-Brain Axis, and Emerging Therapeutics (2026 · Biomedicines · 被引 4)
• Lavandula angustifolia essential oil attenuates chronic prostatitis by inhibiting PI3K/AKT and NF-κB signaling pathways (2025 · International Immunopharmacology · 被引 4)